NCT00379496

Brief Summary

The aim of this study was to evaluate the effect of acupuncture as a treatment for this condition. Fifty-eight women diagnosed with fibromyalgia were randomly allocated to two groups. One group received acupuncture (n=34) twice a week for 20 sessions in addition to tricyclic antidepressants and exercises. The control group (n=24) received only tricyclic antidepressants and exercises. A blinded assessor evaluated patients' pain using visual analog scale (VAS), tender points number (TePsN) and myalgic index (MI). The same assessor also evaluated quality of life (QoL) using SF-36. These evaluations were done prior to treatments, at the end of the 20 sessions, and again at six months, one year and two years after the first evaluation. At the end of the 20 sessions, patients who had received acupuncture were significantly better than those who had not in all measures of pain (VAS, TePsN, MI) and in five subscales of SF-36. After six months, the acupuncture group was significantly better than the control group in some measures of pain (TePsN and MI) and in three subscales of SF-36. After one year, the acupuncture group showed significant advantage in only one subscale of SF-36; at two years there were no significant differences between the two groups on all outcome measures. The addition of acupuncture to usual treatment for fibromyalgia is beneficial for pain and quality of life, but only in first six months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Apr 2000

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2000

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2002

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

September 21, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 22, 2006

Completed
Last Updated

September 22, 2006

Status Verified

September 1, 2006

First QC Date

September 21, 2006

Last Update Submit

September 21, 2006

Conditions

Keywords

FibromyalgiaAcupunctureRandomized study

Outcome Measures

Primary Outcomes (4)

  • VAS(Visual Analogical Scale)

  • SF-36(Short Form 36)

  • Myalgic Index

  • Number of tender points

Secondary Outcomes (4)

  • VAS(Visual Analogical Scale)(5 times)

  • SF-36(Short Form 36)(5 times)

  • Myalgic Index(5 times)

  • Number of tender points(5 times)

Interventions

acupuncturePROCEDURE

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients had to report moderate to severe pain intensity (VAS \> four), and they had to be using antidepressant medication in an analgesic dose (between 12.5mg/day and 75mg/day).

You may not qualify if:

  • Patients were excluded in the case of severe psychiatric disease, the presence of neurological deficits, cardiac disease or glaucoma, and treatment with acupuncture within one year prior to the start of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo

São Paulo, São Paulo, 05403010, Brazil

Location

MeSH Terms

Conditions

Fibromyalgia

Interventions

Antidepressive AgentsAcupuncture Therapy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Psychotropic DrugsCentral Nervous System AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and UsesComplementary TherapiesTherapeutics

Study Officials

  • Rosa A Targino, MD

    University of Sao Paulo-School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 21, 2006

First Posted

September 22, 2006

Study Start

April 1, 2000

Study Completion

May 1, 2002

Last Updated

September 22, 2006

Record last verified: 2006-09

Locations